Navigation Links
Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
Date:4/23/2010

e question is not 'Is it technically possible?' but rather 'Does it make sense clinically from a therapy standpoint?'"

Perfexion improves radiosurgery workflow

Leksell Gamma Knife Perfexion replaced two earlier generation Leksell Gamma Knife® 4C systems, one at Sophiahemmet Hospital and the other at Karolinska University Hospital. Each had been treating about 250 patients per year for the last three years. Since the late 1960s, Karolinska has used Gamma Knife surgery for approximately 10,000 patients, according Dr. Dodoo.

On January 11, Karolinska used Leksell Gamma Knife Perfexion to treat its first case, a patient with a glioblastoma. Since then, Karolinska has treated 120 patients with Perfexion and this single system already rivals the daily patient volume of the previous systems by virtue of its unique features. "We treated five patients in one day last week, including two quite complex cases," he recalls. "With either of our previous systems that would have been logistically difficult. With Perfexion, up to five patients per day is absolutely realistic."

In addition to the system's automated collimator, the enhanced planning system for Leksell Gamma Knife Perfexion also is boosting the efficiency of Karolinska's radiosurgery practice.

"Planning is a lot easier, more intuitive and very user friendly," Dr. Dodoo notes. "We can visualize the isodose lines simultaneously as we trace them and the dynamic shaping makes dose planning much simpler. It really has changed our approach."

The sophisticated automation that Perfexion brings to the clinic has transformed radiosurgery from a hands-on, technical procedure to one in which enhancing dose plans is the key objective, he adds. "Perfexion has allowed us to shift the focus from
'/>"/>

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
2. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
3. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
4. Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR)
5. Karolinska Development: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
9. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
10. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
11. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , August 20, 2014 ... Conducted in the US  KalVista Pharmaceuticals ("KalVista"), ... edema (DME), today announces that it has begun a ... plasma kallikrein inhibitor, KVD001, for the treatment of DME. ... of the Beetham Eye Institute, Joslin Diabetes Center; Harvard ...
(Date:8/19/2014)...  The Alabama Supreme Court, in a 6-3 decision on ... who mislead doctors into believing that prescription medicines the companies ... v. Wyeth, and the decision came after the Supreme Court ... year. Heninger Garrison Davis attorneys Lew Garrison and ... Danny Weeks . The decision won a ...
(Date:8/19/2014)... , Aug. 19, 2014  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... last Thursday, August 14, 2014, has closed.  The three-year ... at $7.30 per share of common stock.  The investors ... purchase up to an additional 30% of these notes ...
Breaking Medicine Technology:KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 3
... Epiphany Biosciences announced,today, the initiation of a ... treatment and management of acute infectious,mononucleosis. Currently, there ... debilitating condition or any other disease caused by,the ... broad spectrum of anti-viral activity,including inhibition of viral ...
... SAN FRANCISCO, Calif., Dec. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... (NYSE: PFE ), has begun a Phase 1 ... syk kinase inhibitor, R343,for the treatment of allergic asthma. ... Under the terms of the companies, 2005 collaboration ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
(Date:8/20/2014)... 20, 2014 Biocide Systems is ... Wrench Advisors as a consultant and partner for ... accounts. , As Wrench Advisors explains on its ... your organization plan and execute programs by leveraging ... channels. Our experience developing joint venture partnerships and ...
(Date:8/20/2014)... 2014 In its latest blog post, ... program that gets clients off to a great start and ... in, is highlighting an important and possibly life-changing – perhaps ... who wants to understand the insidious nature of drug abuse: ... that drug abuse targets a certain socioeconomic group, such as ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The award-winning ... (ACPS), has expanded its presence throughout Houston to a ... Eye Institute and Laser Center building. ACPS plastic surgeon ... step forward for ACPS, which has risen to become ... surgery practices in the state since its establishment in ...
(Date:8/20/2014)... August 20, 2014 Texas Medical Research Associates ... The study will help test the effectiveness of a new ... high cholesterol may be eligible to participate in the study. ... in the blood can lead to cardiovascular disease, the no. ... can help reduce the risk of heart disease and stroke. ...
(Date:8/20/2014)... -- White, straight women are much more likely to ... women, a new study finds. Researchers examined data ... 44, who took part in polls in 2002 and ... Family Growth study. In the first poll, 13 ... for infertility. This ranged from getting advice from doctors ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:Texas Medical Research Associates Announce New Study 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2
... , TUESDAY, April 17 (HealthDay News) -- A group of ... indicators of your chances of living to age 70 than ... challenge the long-held belief that race or the region of ... how long you may live, according to researchers from Stanford ...
... The increasing globalization of the drug supply ... and diversion of medicines, growth of illegal Internet ... into the supply chain. As pharmaceutical companies, regulatory ... determine the best approaches to securing increasingly complex ...
... Randy Dotinga HealthDay Reporter , TUESDAY, April 17 ... value of proton therapy, an expensive new kind of radiation ... the treatment instead of the standard radiation therapy were more ... There also did not appear to be any extra benefit ...
... SEATTLE Larry Corey, M.D., president and director of Fred ... the American Academy of Arts and Sciences, one of the ... centers. , "I,m extremely honored to be in the same ... science, medicine and the arts," Corey said. "I,m also very ...
... April 17 (HealthDay News) -- New research adds to the ... plaques, the brain-clogging fragments that have been associated with Alzheimer,s ... Berlin, researchers report that they were able to use a ... brains of patients whose Alzheimer,s was confirmed after death. ...
... In an analysis of three different types ... cancer, compared with conformal radiation therapy, intensity-modulated radiation ... gastrointestinal adverse effects, hip fractures, and receipt of ... proton therapy was associated with more gastrointestinal adverse ...
Cached Medicine News:Health News:Social Factors May Affect Lifespan More Than Race, Location 2Health News:Global, common approach to pharmaceutical supply chain integrity the focus of workshop 2Health News:Global, common approach to pharmaceutical supply chain integrity the focus of workshop 3Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 3Health News:Hutchinson Center president elected to American Academy of Art and Sciences 2Health News:Hutchinson Center president elected to American Academy of Art and Sciences 3Health News:New Method to Reveal Alzheimer's Marker Shows Promise 2Health News:Study examines adverse effects among different radiation therapies for prostate cancer 2Health News:Study examines adverse effects among different radiation therapies for prostate cancer 3
... 1100RS Spectrophotometers are simple, ... for use in many ... educational, clinical, industrial and ... COD vial holders, Windows ...
Spectra 2000 Digital Spectrophotometer is designed for quantitative and qualitative analysis in visible range from 320 nm to 1020 nm....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... Darkfield Quebec Colony Counter allows the user ... choice of models allows for digital counting or ... over the standard lens increasing magnification to 3.0X. ... lens to be raised or lowered. The lens ...
Medicine Products: